LOGO
LOGO

Breaking News

Youdao Q2 Net Loss Narrows As Revenue Improves

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Youdao, Inc. (DAO), a Chinese online content, communication, community, and other services provider, on Thursday posted a narrower net loss for the second-quarter, supported by increased revenue and decreased operating expenses.

For the three-month period to June 30, the company posted a net loss of RMB99.475 million or RMB0.85 per ADS, compared with a loss of RMB299.159 million or RMB2.45 per ADS, recorded for the same period of previous year.

Excluding items, loss was at RMB 95.966 million or RMB0.82 per share, narrower than a loss of RMB283.575 million or RMB2.32 per share a year ago.

Loss from operations declined to RMB72.553 million from a loss of RMB289.131 million in 2023.

Total operating expenses stood at RMB709.3 million, compared with RMB856.3 million a year ago.

Revenue was RMB1.321 billion, up from RMB1.206 billion a year ago.

Online marketing services generated revenue of RMB511.237 million, higher than last year's RMB303.557 million.

Feng Zhou, CEO of Youdao, said: "Looking ahead, with our teams' continued execution and barring unexpected market changes, we expect the business to achieve full-year positive operating income in the near future. Youdao's strength lies in our unique ability to advance AI empowerment across business lines, combining technical strength with operational excellence."

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

RELATED NEWS
Latest Updates on COVID-19